Formulation and pharmacokinetic evaluation of solid lipid nanoparticles containing an antipsychotic agent for improved oral delivery

• In: Posters D - Formulation Design and Pharmaceutical Technology
• At: PSWC, Melbourne (Australia) (2014)
• Type: Poster
• Poster code: PD-059
• By: NATARAJAN, Jawahar (Jss college of pharmacy, Pharmaceutics, Ootacamund, India)
• Co-author(s): Meyyanathan (Jss college of pharmacy, Ootcamund, India)
  Jubie (Jss college of pharmacy, Ootacamund, India)
  Dhanabal (Jss college of pharmacy, Ootacamund, India)
  
• Abstract:

  Background: Olanzapine is a psychotropic agent that belongs to the thioenobenzodiazepine class and is indicated for acute and maintenance treatment of schizophrenia. The conventional formulations of olanzapine suffer from low bioavailability (40%) and wide variety of side effects are associated with current dosage forms of the drug. It is..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login